1. Home
  2. MTH vs LQDA Comparison

MTH vs LQDA Comparison

Compare MTH & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

N/A

Current Price

$61.76

Market Cap

4.4B

ML Signal

N/A

LQDA

Liquidia Corporation

N/A

Current Price

$54.43

Market Cap

4.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTH
LQDA
Founded
1985
2004
Country
United States
United States
Employees
N/A
216
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.9B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MTH
LQDA
Price
$61.76
$54.43
Analyst Decision
Hold
Buy
Analyst Count
10
8
Target Price
★ $69.63
$66.13
AVG Volume (30 Days)
911.4K
★ 2.4M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
★ 3.13%
N/A
EPS Growth
N/A
★ 51.81
EPS
★ 3.22
N/A
Revenue
N/A
★ $158,320,000.00
Revenue This Year
N/A
$379.76
Revenue Next Year
$2.85
$25.58
P/E Ratio
$19.04
★ N/A
Revenue Growth
N/A
★ 1031.18
52 Week Low
$56.66
$22.31
52 Week High
$85.38
$93.61

Technical Indicators

Market Signals
Indicator
MTH
LQDA
Relative Strength Index (RSI) 43.50 58.91
Support Level $57.94 $53.06
Resistance Level $76.89 $59.50
Average True Range (ATR) 2.29 3.44
MACD -0.79 1.01
Stochastic Oscillator 8.85 71.72

Price Performance

Historical Comparison
MTH
LQDA

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: